Fig. 2From: The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID studyFlow chart outlining patient enrollment and allocation for studyBack to article page